PRAX – praxis precision medicines, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

PRAX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/1

08:09 am

prax

Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $250.00 price target on the stock.

Medium Report

Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $250.00 price target on the stock.

Report

12/1

05:35 am

prax

Rating for PRAX

Medium Report

Rating for PRAX

Report

12/1

05:35 am

prax

Rating for PRAX

Medium Report

Rating for PRAX

Report

11/25

08:07 am

prax

Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $258.00 price target on the stock.

Low Report

Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $258.00 price target on the stock.

Report

11/21

05:31 am

prax

Praxis Precision Medicines (NASDAQ:PRAX) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.

Medium Report

Praxis Precision Medicines (NASDAQ:PRAX) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.

Report

11/20

06:02 am

prax

Praxis Precision Medicines (NASDAQ:PRAX) was upgraded by analysts at BTIG Research to a "strong-buy" rating.

Medium Report

Praxis Precision Medicines (NASDAQ:PRAX) was upgraded by analysts at BTIG Research to a "strong-buy" rating.

Report

11/19

05:14 am

prax

Rating for PRAX

Low Report

Rating for PRAX

Report

11/18

04:17 pm

prax

Praxis Precision initiated with a Buy at BTIG

Low Report

Praxis Precision initiated with a Buy at BTIG

Report

11/6

06:05 pm

prax

Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Guggenheim.

Low Report

Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Guggenheim.

Report

11/6

06:05 pm

prax

Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Guggenheim.

Low Report

Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Guggenheim.

Report

11/6

08:29 am

prax

Rating for PRAX

Low Report

Rating for PRAX

Report

11/6

08:29 am

prax

Rating for PRAX

Low Report

Rating for PRAX

Report

10/20

09:12 am

prax

Rating for PRAX

Medium Report

Rating for PRAX

Report

10/20

09:12 am

prax

Rating for PRAX

Medium Report

Rating for PRAX

Report

10/17

08:49 am

prax

Rating for PRAX

High Report

Rating for PRAX

Report

10/17

08:49 am

prax

Rating for PRAX

High Report

Rating for PRAX

Report

10/17

07:53 am

prax

Rating for PRAX

High Report

Rating for PRAX

Report

10/17

07:23 am

prax

Rating for PRAX

High Report

Rating for PRAX

Report

10/17

07:23 am

prax

Rating for PRAX

High Report

Rating for PRAX

Report

10/16

03:40 pm

prax

Rating for PRAX

Medium Report

Rating for PRAX

Report

10/16

03:40 pm

prax

Rating for PRAX

Medium Report

Rating for PRAX

Report

10/16

12:58 pm

prax

Rating for PRAX

Medium Report

Rating for PRAX

Report

10/16

12:58 pm

prax

Rating for PRAX

Medium Report

Rating for PRAX

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.